Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Skin may tighten gradually over time, but outcomes vary
Because retatrutide also activates the GLP-1 receptor, the same preclinical concern applies [2]
Research Rationale Retatrutide addresses systemic energy homeostasis through incretin and glucagon receptor signalling MOTS-C targets cellular energy sensing via AMPK and mitochondrial regulation Triple agonism (GLP-1 + GIP + glucagon) provides broader receptor coverage than single or dual agonists, while MOTS-C adds a mitochondrial dimension not addressed by incretin-based compounds Retatrutide modulates insulin and glucagon secretion in glucose-dependent in vitro models MOTS-C enhances glucose uptake and fatty acid oxidation in cultured myocytes and hepatocytes Each peptide is individually vialled with independent batch COAs titrate each separately in your assay design Research Applications Commonly employed in metabolic disease research using beta-cell lines (MIN6, INS-1), primary hepatocyte cultures, and 3T3-L1 adipocyte differentiation models
When you do quit, immune function begins to improve within 30 days
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
